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Figure S1. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-oxo-4-(o-tolyl)but-2-enoic acid (2). 
  
 
Figure S2. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-oxo-4-(m-tolyl)but-2-enoic acid (3). 
 
 
Figure S3. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-4-(4-butylphenyl)-2-hydroxy-4-oxobut-2-enoic acid (4). 
  
  
Figure S4. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-4-(2,4-dimethylphenyl)-2-hydroxy-4-oxobut-2-enoic 
acid (5). 
  
  
Figure S5. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-oxo-4-(2,4,5-trimethylphenyl)but-2-enoic  
acid (6). 
  
Figure S6. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-oxo-4-(2,3,5,6-tetramethylphenyl)but-2-
enoic acid (7). 
  
Figure S7. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-oxo-4-(5,6,7,8-tetrahydronaphthalen-2-
yl)but-2-enoic acid (8). 
  
Figure S8. 1D 
1
H and 1D 
13
C NMR spectra of 1-(4-ethyl-2,6-diisopropylphenyl)ethanone (5a). 
  
Figure S9. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-oxo-4-(2,4,6-triisopropylphenyl)but-2-enoic 
acid (9). 
  
Figure S10. 1D 
1
H and 1D 
13
C NMR spectra of  4-oxo-4-(2,4,6-triisopropylphenyl)butanoic acid (2a). 
  
Figure S11. 1D 
1
H and 1D 
13
C NMR spectra of 4-([1,1'-biphenyl]-4-yl)-4-oxobutanoic acid (3a). 
  
 
Figure S12. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-(4-methoxy-2,5-dimethylphenyl)-4-oxobut-
2-enoic acid (10). 
  
 
 
 
Figure S13. 1D 
1
H NMR spectrum of (Z)-2-hydroxy-4-(4-hydroxy-3,5-dimethylphenyl)-4-oxobut-2-enoic 
acid (11). 
  
  
 
Figure S14. 1D 
1
H spectrum of 1-(2,5-dicyclohexylphenyl)ethanone (4a). 
  
  
 
Figure S15. 1D 
1
H and 1D 
13
C NMR spectra of  (Z)-4-(2,5-dicyclohexylphenyl)-2-hydroxy-4-oxobut-2-
enoic acid (12).  
  
Figure S16. 1D 
1
H NMR spectrum of 4-(2,5-dicyclohexylphenyl)-4-oxobutanoic acid (1a).   
  
Figure S17. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-(2-methoxyphenyl)-4-oxobut-2-enoic acid 
(13). 
 
  
Figure S18. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-(3-methoxyphenyl)-4-oxobut-2-enoic acid 
(14).  
 
  
Figure S19. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-4-(3-bromophenyl)-2-hydroxy-4-oxobut-2-enoic acid 
(15). 
 
  
Figure S20. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-oxo-4-(3-(trifluoromethyl)phenyl)but-2-
enoic acid (16). 
 
  
Figure S21. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-oxo-4-(4-(pyrrolidin-1-yl)phenyl)but-2-
enoic acid (17). 
  
  
Figure S22. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-(4-morpholinophenyl)-4-oxobut-2-enoic 
acid (18).  
 
  
Figure S23. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-4-(4-(1H-imidazol-1-yl)phenyl)-2-hydroxy-4-oxobut-2-
enoic acid (19). 
  
Figure S24. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-2-hydroxy-4-(4-(4-methylpiperazin-1-yl)phenyl)-4-
oxobut-2-enoic acid (20). 
  
Figure S25. 1D 
1
H and 1D 
13
C NMR spectra of (Z)-4-(4-(dimethylamino)phenyl)-2-hydroxy-4-oxobut-2-
enoic acid (21).   
   
Figure S26. Changes in fluorescence emission spectra of HSA (c = 0.5 µM) upon addition of comp. 12 (c12 
= 0.0; 0.25; 0.5; 0.75; 1; 1.5; 2.0; 3.0; 4.0 µM); T = 293 K, left; T = 313 K, right; 30 mM PBS, pH = 7.38. 
 
